Sep 9, 2024 08:33AM Kintara Therapeutics (KTRA) to Hold Special Meeting of Stockholders to Allow for Completion of the Proposed Merger with TuHURA Biosciences, Inc.

Aug 19, 2024 09:13AM TuHURA Biosciences and Kintara Therapeutics (KTRA) Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer

Aug 19, 2024 09:00AM TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer

Jul 8, 2024 06:31AM TuHURA Biosciences Enters Exclusivity and Right of First Offer Agreement for Kineta's (KTRA) KVA12123

Jul 8, 2024 06:30AM TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.’s KVA12123 Novel anti-VISTA Checkpoint Inhibitor

Jul 1, 2024 08:35AM Kintara Therapeutics (KTRA) and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones

Jul 1, 2024 08:35AM Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones